WO1998031735A1 - Improved polypropylene suture material - Google Patents
Improved polypropylene suture material Download PDFInfo
- Publication number
- WO1998031735A1 WO1998031735A1 PCT/US1997/012328 US9712328W WO9831735A1 WO 1998031735 A1 WO1998031735 A1 WO 1998031735A1 US 9712328 W US9712328 W US 9712328W WO 9831735 A1 WO9831735 A1 WO 9831735A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- suture material
- branched chain
- improved
- polypropylene
- surgical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L17/00—Materials for surgical sutures or for ligaturing blood vessels ; Materials for prostheses or catheters
- A61L17/04—Non-resorbable materials
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L23/00—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
- C08L23/02—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers not modified by chemical after-treatment
- C08L23/10—Homopolymers or copolymers of propene
- C08L23/12—Polypropene
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L91/00—Compositions of oils, fats or waxes; Compositions of derivatives thereof
- C08L91/06—Waxes
Definitions
- This invention is drawn to an improved extrusion grade polypropylene based formulation suitable for use as surgical suture material.
- the improved suture material possesses enhanced physical properties including: suppleness, softness, fray resistance, knot retention and skin slipperiness.
- the present invention is drawn to an improved formulation for polypropylene.
- This improved formulation is useful in the production of surgical sutures and the like.
- surgical sutures made of polypropylene have suffered from the drawbacks of: (1) lacking suppleness and softness; (2) being prone to fraying when a surgical knot is slid down the suture; and (3) not maintaining skin slipperiness.
- sutures Menezes et al, in U.S. Patent Nos. 4,520,822 and 4,620,542 disclose surgical monofilament sutures.
- the sutures are said to possess improved compliance, compared with polypropylene homopolymer sutures.
- these sutures suffer from the above drawbacks.
- the sutures of the present invention possess superior suppleness, softness, fray resistance, knot retention and skin slipperiness.
- Hinsch in U.S. Patent No. 4,577,264 discloses surgical filaments such as sutures and ligatures made of a blend of polypropylene and linear low density polyethylene. These sutures are not subject to the above drawbacks.
- the present invention overcomes the same drawbacks without the need for a low density polyethylene additive.
- the present invention attains these superior properties by incorporating a branched chain polyolefin wax, such as a polyethylene wax, into the blend. Additionally, the present invention attains these superior properties with lower concentrations of additive than is taught by the Hinch reference.
- the object of present invention is to provide an improved formulation for polypropylene useful in the production of surgical sutures and the like. It is a further objective of the present invention to provide for a surgical suture material having improved suppleness, softness, fray resistance, knot retention and having improved skin slipperiness.
- a further object of the present invention is to provide for an improved additive package to be used in combination with typical extrusion grade polypropylene formulations.
- Another object of the invention is to provide for a suture material suitable for use within the human body.
- the improved suture material must be suitable for use in surgical material. That is, the material must be approved by the relevant governmental agency(s) regulating materials suitable for use in medical application.
- the present invention provides for a polypropylene surgical material comprising extrusion grade polypropylene.
- the polypropylene is made as is common in the art. For example, as disclosed in the '264 reference.
- the improvement comprises the addition of a branched chain polyolefin wax, to a typical additive package for polypropylene blend suture material.
- Typical polypropylene suture material composition additive packages are well known in the art. For example, additive packages as disclosed in any of the cited references.
- the present invention is an improved material suitable for use as a surgical suture material.
- the material comprises extrusion grade polypropylene suitable for use as a surgical suture material and the like. These materials are well known in the art.
- the material comprises a polypropylene homopolymer.
- F-040-A suture grade polypropylene material manufactured by Aristech Chemical Corporation.
- the improvement of the present invention comprises the addition of a branched chain polyolefin wax to the polypropylene blend formulation.
- the olefin wax is a branched chain low molecular weight polyolefin wax such as a branched chain low molecular weight polyethylene wax.
- a branched chain low molecular weight polyethylene wax such as AC-617, manufactured by Allied Signal.
- the was is added in an amount of about 0.1 to 2.0 wt%. Preferably, 0.5 to 0.95 wt%.
- a 2 melt flow homopolymer reactor powder is blended in: 0.2 wt% of a lubricant such as calcium stearate; 0.2 wt% anti-static agent, 0.4 wt% of a thermal stabilizer, 0.2 wt% of a primary anti-oxidant, and 0.75 wt% AC-617 branched chain low molecular weight polyethylene wax. Wherein all additive quantities measured +/- 20%.
- a lubricant such as calcium stearate
- anti-static agent 0.2 wt% anti-static agent
- 0.4 wt% of a thermal stabilizer 0.2 wt% of a primary anti-oxidant
- 0.75 wt% AC-617 branched chain low molecular weight polyethylene wax 0.75 wt% AC-617 branched chain low molecular weight polyethylene wax.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Surgery (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Materials For Medical Uses (AREA)
- Artificial Filaments (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Abstract
The present invention is an improved composition suitable for use as a surgical suture material. The composition comprises the addition of a branched chain polyolefin wax to typical extrusion grade polypropylene suitable for surgical applications. The improved suture material enhances the suppleness, softness, fray resistance, knot retention and skin slipperiness of the suture material.
Description
IMPROVED POLYPROPYLENE SUTURE MATERIAL
Technical Field
This invention is drawn to an improved extrusion grade polypropylene based formulation suitable for use as surgical suture material. The improved suture material possesses enhanced physical properties including: suppleness, softness, fray resistance, knot retention and skin slipperiness.
Background of the Invention
The present invention is drawn to an improved formulation for polypropylene. This improved formulation is useful in the production of surgical sutures and the like. Until now, surgical sutures made of polypropylene have suffered from the drawbacks of: (1) lacking suppleness and softness; (2) being prone to fraying when a surgical knot is slid down the suture; and (3) not maintaining skin slipperiness.
Menezes et al, in U.S. Patent Nos. 4,520,822 and 4,620,542 disclose surgical monofilament sutures. The sutures are said to possess improved compliance, compared with polypropylene homopolymer sutures. However, these sutures suffer from the above drawbacks. The sutures of the present invention possess superior suppleness, softness, fray resistance, knot retention and skin slipperiness.
Hinsch, in U.S. Patent No. 4,577,264 discloses surgical filaments such as sutures and ligatures made of a blend of polypropylene and linear low density polyethylene. These sutures are not subject to the above drawbacks. However, the present invention overcomes the same drawbacks without the need for a low
density polyethylene additive. The present invention attains these superior properties by incorporating a branched chain polyolefin wax, such as a polyethylene wax, into the blend. Additionally, the present invention attains these superior properties with lower concentrations of additive than is taught by the Hinch reference.
Object of the Invention
The object of present invention is to provide an improved formulation for polypropylene useful in the production of surgical sutures and the like. It is a further objective of the present invention to provide for a surgical suture material having improved suppleness, softness, fray resistance, knot retention and having improved skin slipperiness.
A further object of the present invention is to provide for an improved additive package to be used in combination with typical extrusion grade polypropylene formulations.
Another object of the invention is to provide for a suture material suitable for use within the human body. As is required in the art, the improved suture material must be suitable for use in surgical material. That is, the material must be approved by the relevant governmental agency(s) regulating materials suitable for use in medical application.
The present invention provides for a polypropylene surgical material comprising extrusion grade polypropylene. The polypropylene is made as is common in the art. For example, as disclosed in the '264 reference. The improvement comprises the addition of a branched chain polyolefin wax, to a typical additive package for polypropylene blend suture material. Typical polypropylene suture material composition additive packages are well known in the art. For example, additive packages as disclosed in any of the cited
references.
Detailed Description of the Invention
The present invention is an improved material suitable for use as a surgical suture material. The material comprises extrusion grade polypropylene suitable for use as a surgical suture material and the like. These materials are well known in the art. Preferably, the material comprises a polypropylene homopolymer. For example, F-040-A suture grade polypropylene material manufactured by Aristech Chemical Corporation.
The improvement of the present invention comprises the addition of a branched chain polyolefin wax to the polypropylene blend formulation. Preferably, the olefin wax is a branched chain low molecular weight polyolefin wax such as a branched chain low molecular weight polyethylene wax. For example, AC-617, manufactured by Allied Signal. The was is added in an amount of about 0.1 to 2.0 wt%. Preferably, 0.5 to 0.95 wt%.
The invention is illustrated by the following Example:
Example 1
To a set quantity of a 2 melt flow homopolymer reactor powder is blended in: 0.2 wt% of a lubricant such as calcium stearate; 0.2 wt% anti-static agent, 0.4 wt% of a thermal stabilizer, 0.2 wt% of a primary anti-oxidant, and 0.75 wt% AC-617 branched chain low molecular weight polyethylene wax. Wherein all additive quantities measured +/- 20%. The above composition is extruded into pellet form. The pellets are later extruded into suture filaments.
Claims
1. A composition suitable for surgical suture material comprising a blend of:
(a) an extrusion grade polypropylene composition; and
(b) 0.1-0.95 wt % of a branched chain polyolefin wax.
2. A composition according to claim 1 wherein 0.5-0.95 wt% of the branched chain polyolefin wax is added.
3. A composition according to claim 1 wherein the branched chain polyolefin wax is a branched chain low molecular weight polyethylene wax.
4. A composition according to claim 1 wherein the polypropylene is an extrusion grade homopolymer.
5. A suture material comprising a blend of:
(a) an extrusion grade polypropylene composition; and
(b) 0.1-0.95 wt% of a branched chain polyolefin wax.
6. A method of making a surgical suture comprising the steps of:
(a) blending: an extrusion grade polypropylene composition and 0.1-0.95 wt% of a branched chain polyolefin wax to make a blend;
(b) extruding the blend into at least one surgical suture filament.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US78659497A | 1997-01-21 | 1997-01-21 | |
| US08/786,594 | 1997-01-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO1998031735A1 true WO1998031735A1 (en) | 1998-07-23 |
Family
ID=25139044
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US1997/012328 WO1998031735A1 (en) | 1997-01-21 | 1997-07-14 | Improved polypropylene suture material |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO1998031735A1 (en) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002076521A2 (en) * | 2001-03-26 | 2002-10-03 | Tyco Healthcare Group Lp | Polyolefin sutures having improved processing and handling characteristics |
| WO2009152487A3 (en) * | 2008-06-13 | 2010-08-19 | Smith & Nephew, Inc. | Fixation devices for tissue repair |
| WO2012162135A1 (en) * | 2011-05-20 | 2012-11-29 | The Procter & Gamble Company | A disposable article comprising fibers of polymer -wax compositions |
| WO2012162130A1 (en) * | 2011-05-20 | 2012-11-29 | The Procter & Gamble Company | Fibers of polymer-wax compositions |
| US9205006B2 (en) | 2013-03-15 | 2015-12-08 | The Procter & Gamble Company | Absorbent articles with nonwoven substrates having fibrils |
| US9504610B2 (en) | 2013-03-15 | 2016-11-29 | The Procter & Gamble Company | Methods for forming absorbent articles with nonwoven substrates |
| US11090407B2 (en) | 2017-03-09 | 2021-08-17 | The Procter & Gamble Company | Thermoplastic polymeric materials with heat activatable compositions |
| US11110013B2 (en) | 2014-09-10 | 2021-09-07 | The Procter & Gamble Company | Nonwoven webs with hydrophobic and hydrophilic layers |
| US11129919B2 (en) | 2016-03-09 | 2021-09-28 | The Procter & Gamble Company | Absorbent article with activatable material |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3791388A (en) * | 1971-09-22 | 1974-02-12 | Ethicon Inc | Covered suture |
| US4701487A (en) * | 1983-06-06 | 1987-10-20 | Petrolite Corporation | Extrusion processing aid composition and polyolefin containing same |
-
1997
- 1997-07-14 WO PCT/US1997/012328 patent/WO1998031735A1/en active Application Filing
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3791388A (en) * | 1971-09-22 | 1974-02-12 | Ethicon Inc | Covered suture |
| US4701487A (en) * | 1983-06-06 | 1987-10-20 | Petrolite Corporation | Extrusion processing aid composition and polyolefin containing same |
Cited By (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002076521A2 (en) * | 2001-03-26 | 2002-10-03 | Tyco Healthcare Group Lp | Polyolefin sutures having improved processing and handling characteristics |
| WO2002076521A3 (en) * | 2001-03-26 | 2003-02-27 | Tyco Healthcare | Polyolefin sutures having improved processing and handling characteristics |
| WO2009152487A3 (en) * | 2008-06-13 | 2010-08-19 | Smith & Nephew, Inc. | Fixation devices for tissue repair |
| US9926653B2 (en) | 2011-05-20 | 2018-03-27 | The Procter & Gamble Company | Fibers of polymer-wax compositions |
| WO2012162130A1 (en) * | 2011-05-20 | 2012-11-29 | The Procter & Gamble Company | Fibers of polymer-wax compositions |
| CN103562291A (en) * | 2011-05-20 | 2014-02-05 | 宝洁公司 | Fibers of polymer-wax compositions |
| CN103561780A (en) * | 2011-05-20 | 2014-02-05 | 宝洁公司 | A disposable article comprising fibers of polymer-wax compositions |
| US11339514B2 (en) | 2011-05-20 | 2022-05-24 | The Procter & Gamble Company | Fibers of polymer-wax compositions |
| US9328440B2 (en) | 2011-05-20 | 2016-05-03 | The Procter & Gamble Company | Fibers of polymer-wax compositions |
| US10151055B2 (en) | 2011-05-20 | 2018-12-11 | The Procter & Gamble Company | Fibers of polymer-wax compositions |
| WO2012162135A1 (en) * | 2011-05-20 | 2012-11-29 | The Procter & Gamble Company | A disposable article comprising fibers of polymer -wax compositions |
| US10016319B2 (en) | 2013-03-15 | 2018-07-10 | The Procter & Gamble Company | Absorbent articles with nonwoven substrates having fibrils |
| US9974700B2 (en) | 2013-03-15 | 2018-05-22 | The Procter & Gamble Company | Absorbent articles with nonwoven substrates having fibrils |
| US9504610B2 (en) | 2013-03-15 | 2016-11-29 | The Procter & Gamble Company | Methods for forming absorbent articles with nonwoven substrates |
| US10993855B2 (en) | 2013-03-15 | 2021-05-04 | The Procter & Gamble Company | Absorbent articles with nonwoven substrates having fibrils |
| US9205006B2 (en) | 2013-03-15 | 2015-12-08 | The Procter & Gamble Company | Absorbent articles with nonwoven substrates having fibrils |
| US11110013B2 (en) | 2014-09-10 | 2021-09-07 | The Procter & Gamble Company | Nonwoven webs with hydrophobic and hydrophilic layers |
| US11839531B2 (en) | 2014-09-10 | 2023-12-12 | The Procter And Gamble Company | Nonwoven webs with hydrophobic and hydrophilic layers |
| US11129919B2 (en) | 2016-03-09 | 2021-09-28 | The Procter & Gamble Company | Absorbent article with activatable material |
| US11090407B2 (en) | 2017-03-09 | 2021-08-17 | The Procter & Gamble Company | Thermoplastic polymeric materials with heat activatable compositions |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4557264A (en) | Surgical filament from polypropylene blended with polyethylene | |
| EP0165500B1 (en) | Surgical filaments from vinylidene fluoride copolymers | |
| CA1134088A (en) | Silicone-containing thermoplastic polymers for medical uses | |
| US7375146B2 (en) | PVA-containing compositions | |
| CA1258410A (en) | Dry coating of surgical filaments | |
| WO1998031735A1 (en) | Improved polypropylene suture material | |
| JPH0662839B2 (en) | Microbial degradable plastic molding and method for producing the same | |
| US20090004470A1 (en) | Inorganic-organic melt-extruded hybrid filaments and medical applications thereof | |
| CA2120104A1 (en) | Multiconstituent fibers, and nonwoven structures of such fibers | |
| EP0686390A2 (en) | Novel compositions for dental floss | |
| US5478355A (en) | Method for improving the in vivo strength retention of a bioabsorbable implantable medical device and resulting medical device | |
| EP1123715B1 (en) | Non-sticky medical tubing | |
| US5681894A (en) | Soft, flexible tampon applicator and method for making same | |
| JPS61136533A (en) | Composition | |
| EP0136916A2 (en) | Anthithrombic resin composition | |
| CA2050020C (en) | Polymeric web compositions for use in absorbent articles | |
| EP0566357A1 (en) | Biodegradable poly(hydroxy carboxylic acid) composition and shaped body thereof | |
| WO2006075174A2 (en) | Pva-containing compositions | |
| US5149333A (en) | Polymeric web compositions for use in absorbent articles | |
| JP3366946B2 (en) | Surgical suture | |
| US11667776B2 (en) | Fiber with odor control component | |
| GB2031441A (en) | Polypyrrolidone-iodine complex | |
| CA1119748A (en) | Polypyrrolidone-iodine complex | |
| JPH10279703A (en) | Wrapping film for retaining freshness | |
| JP3001609B2 (en) | Tube with contrast agent |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): CA JP |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| NENP | Non-entry into the national phase |
Ref country code: CA |
|
| 122 | Ep: pct application non-entry in european phase |